Minerva Neurosciences, Inc. Number of Reportable Segments
Minerva Neurosciences, Inc. (NERV) reported Number of Reportable Segments of 1 Segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-07
- Minerva Neurosciences, Inc. number of reportable segments for the quarter ending 2026-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- Minerva Neurosciences, Inc. number of reportable segments for the quarter ending 2025-03-31 was 1.00 Segment.
- Minerva Neurosciences, Inc. number of reportable segments for fiscal 2025 was 1.00 Segment, a 0.00% change from fiscal 2024.
- Minerva Neurosciences, Inc. number of reportable segments for fiscal 2024 was 1.00 Segment.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 Segment 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | 1.00 Segment 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | 1.00 Segment 10-K · filed 2026-03-11 | |||
| 2025-09-30 | 1.00 Segment 10-Q · filed 2025-11-05 | |||
| 2025-06-30 | 1.00 Segment 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | 1.00 Segment 10-Q · filed 2025-05-13 | |||
| 2024-12-31 | 1.00 Segment 10-K · filed 2025-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |